The Mother's Service Society

Work & Mother Announces Collaboration with Jamestown to Provide State-of-the-Art Lactation Suites in Select Commercial Buildings

Retrieved on: 
Tuesday, February 7, 2023
Asset management, Milk, Tremont Street, HUB, Working Mother, Workplace, Work, The Mother's Service Society, Workforce, Senior, Health, Parent, Fair Labor Standards Act of 1938, Absenteeism, Data, Heart, Partnership, Innovation, Lactation, FLSA, Property management, Nursing

HOUSTON and FARMINGTON, Conn., Feb. 7, 2023 /PRNewswire/ -- Work & Mother Services, Inc. (Work & Mother), a full-service lactation suite with an associated support resource, the HUB, announces today it has entered into an agreement with Jamestown to deliver commercial lactation suites as tenant amenities for two commercial office buildings in Boston, Massachusetts, and Arlington, Virginia, part of the Washington, D.C. market.

Key Points: 
  • In addition to the physical lactation suites, Work & Mother's virtual resource center, the HUB , provides information and services specifically tailored to parents working both in and out of the home.
  • The partnership between Work & Mother and Jamestown comes on the heels of the recent bipartisan passing of the Providing Urgent Maternal Protections (PUMP) for Nursing Mothers Act.
  • "Work & Mother's lactation suites promote a healthy work/life balance for working mothers and help create a more equitable workplace environment for our tenants."
  • The Work & Mother suites at 18 Tremont and Ballston Exchange are expected to be complete by Summer 2023.

Work & Mother partners with Nest Collaborative to provide virtual lactation consultations for working mothers

Retrieved on: 
Wednesday, January 18, 2023
Donnell, Work, Parental leave, Parent, Medicaid, American Academy of Pediatrics, Working Mother, Workplace, Mother, Trial balance, International, Lactation, Health, Partnership, Woman, Nest, The Mother's Service Society, American Academy, Workforce, HUB, Milk, AAP, Female, Animal, Birth control

The partnership between Work & Mother and Nest Collaborative will make it easier for parents to return to work after childbirth by providing them access to Nest Collaborative's IBCLCs through the app associated with Work & Mother's office lactation suites.

Key Points: 
  • The partnership between Work & Mother and Nest Collaborative will make it easier for parents to return to work after childbirth by providing them access to Nest Collaborative's IBCLCs through the app associated with Work & Mother's office lactation suites.
  • With Work & Mother, employees can book private rooms within the lactation suite via the Work & Mother app.
  • Now, families will be able to quickly book appointments and have direct access to Nest Collaborative IBCLCs, right through the Work & Mother HUB.
  • "We're excited to partner with Nest Collaborative and further expand access to premium lactation support services for Work & Mother Suite users and their employers.

Nautilus Biotechnology Appoints Karen Akinsanya, Ph.D., to Board of Directors

Retrieved on: 
Thursday, March 31, 2022
Trustee, Therapy, Register, Research, SEC, Physiology, Medicine, CEO, Exploration, Royal Postgraduate Medical School, Technology, Rockefeller University, GLOBE, Thermo Fisher Scientific, Annual report, Chairperson, Health, Senior, National Medical Fellowships, Student, Science, Imperial College London, AVP, Pharmacy, NASDAQ, DNA, Form, Forward-looking statement, Board, Pharmacology, Proteome, Genomics, Proteoform, Board of directors, The Mother's Service Society, San Francisco Bay Area, Drug discovery, Protein, Business development, Queen Mary University of London, Biochemistry, Leadership, Clinical pharmacology, Coronavirus Scientific Advisory Board (Turkey), Associate, Mother, Doctor of Philosophy, Merck & Co., R, Proteomics, Pharmaceutical industry, Management, Nautilus, Merck, Illumina

SEATTLE, March 31, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or Nautilus), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the appointment of Karen Akinsanya, Ph.D., to its Board of Directors.

Key Points: 
  • SEATTLE, March 31, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or Nautilus), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the appointment of Karen Akinsanya, Ph.D., to its Board of Directors.
  • in biochemistry at Queen Mary University of London, and her Ph.D. in endocrine physiology from the Royal Postgraduate Medical School at Imperial College in London.
  • Nautilus mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine.
  • Except as otherwise required by applicable law, Nautilus disclaims any duty to update any forward-looking statements.